Amedisys Inc (AMED) News
Filter AMED News Items
AMED News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AMED News Highlights
- AMED's 30 day story count now stands at 6.
- Over the past 16 days, the trend for AMED's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- ST are the most mentioned tickers in articles about AMED.
Latest AMED News From Around the Web
Below are the latest news stories about AMEDISYS INC that investors may wish to consider to help them evaluate AMED as an investment opportunity.
Former Amedisys CEO gets $4 million severance package on his way outChristopher Gerard, the former president and CEO of Amedisys, will receive a $4.05 million severance package after being fired from the Baton Rouge home health care giant in November, according |
Be Wary Of Amedisys (NASDAQ:AMED) And Its Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to... |
15 Biggest Nursing Home Companies in the USIn this article, we will discuss the 15 biggest nursing home companies in the US. If you wish to skip over the industry analysis, go directly to the 5 Biggest Nursing Home Companies in the US. The nursing home market size in the US currently stands at $148.4 billion. The industry employs over 1.5 million people. […] |
Amedisys (AMED) Faces Macro Challenges, Margin PressureThe Contessa Health acquisition seems to be strategically aligned with Amedisys' (AMED) business. |
Amedisys to Present at the 41st Annual J.P. Morgan Healthcare ConferenceBATON ROUGE, La., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Monday, January 9 at 8:15 p.m. ET (5:15 p.m. PT). |
A stock that deserves closer examination: Amedisys Inc. (AMED)Amedisys Inc. (NASDAQ:AMED) marked $81.75 per share on Friday, up from a previous closing price of $81.56. While Amedisys Inc. has overperformed by 0.23%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMED fell by -49.38%, with highs and lows ranging from $179.91 to $79.48, whereas […] |
Computerworld Names Amedisys to 2023 List of Best Places to Work in ITBATON ROUGE, La., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Foundry’s Computerworld recently named Amedisys, Inc. (NASDAQ: AMED) one of the nation’s leading home health, hospice, personal and high-acuity care companies, to their 2023 listing of the Best Places to Work in IT. This award recognizes the top organizations that challenge their IT staffs while providing great benefits and compensation. Organizations will be included in coverage on Computerworld.com along with results from the 2023 Best Places |
Amedisys finalizes home health joint venture with University of ArkansasHome health, hospice, personal care and high-acuity care company Amedisys Inc. announced it has closed on a joint venture with the University of Arkansas for Medical Sciences, or UAMS, to provide home health services to 12 counties in central Arkansas. |
Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical SciencesLITTLE ROCK, Ark. and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock. This joint venture is part of the partnership between UAMS, Amedisys and Contessa, an Amedisys company, to offer patients a full spectrum of medical care in |
Declining Stock and Solid Fundamentals: Is The Market Wrong About Amedisys, Inc. (NASDAQ:AMED)?It is hard to get excited after looking at Amedisys' (NASDAQ:AMED) recent performance, when its stock has declined 29... |